Last week, the Chancery Court issued its post-trial opinion in Camaisa v. Pharmaceutical Research Associates, (Del. Ch.; 10/25), which involved fraud claims arising out of alleged oral statements made by a buyer’s representative concerning the autonomy of an acquired business. When the business subsequently failed to achieve contractual earnout milestones, the plaintiff sued, raising the alleged oral […]